Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donors After Reduced-intensity Conditioning: a Phase II Randomized Study Comparing 2 GVHD Prophylaxis Regimens

NCT01428973 is registered in ClinicalTrials.gov with University of Liege as lead sponsor.

NCT NCT01428973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donors After Reduced-intensity Conditioning: a Phase II Randomized Study Comparing 2 GVHD Prophylaxis Regimens
Lead sponsor
University of Liege
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2011
Completion date
December 31, 2024
Enrollment
200 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

graft-versus-host disease, hematological malignancies